|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 15-02-04 | AbbVie : Merck says hepatitis C drugs to lose breakthrough status | RE |
| 14-06-10 | Apple : Wall St. edges up, lifted by mergers, acquisitions | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | - | - | - | - | - | 0 | |
| -0.26% | +3.42% | +24.01% | +28.29% | +7.99% | +41.04% | -1.28% | +25.67% | +99.10% | 83.96B | |
| -16.64% | +119.43% | +134.78% | +190.25% | +373.62% | +419.41% | +25.74% | -63.53% | - | 69.62B | |
| +2.84% | +23.66% | +38.83% | +73.47% | -0.84% | -24.08% | -36.73% | -43.47% | +58.68% | 56.76B | |
| +1.94% | +1.61% | +12.75% | +16.94% | -7.14% | -0.03% | +32.78% | +5.00% | - | 51.35B | |
| -0.78% | -1.37% | -9.20% | -9.43% | -9.43% | +10.71% | +165.15% | +118.24% | +196.03% | 48.41B | |
| -0.79% | +3.98% | +9.54% | +16.63% | +24.46% | +57.59% | -17.37% | -35.91% | -30.86% | 32.74B | |
| +0.60% | +7.08% | +11.59% | +32.93% | +30.66% | +49.71% | +98.91% | +72.30% | +57.42% | 26.04B | |
| +3.00% | +5.91% | +13.77% | +26.50% | +32.72% | +3.53% | +221.78% | +50.60% | - | 21.81B | |
| -0.86% | +2.76% | -0.43% | +5.64% | +38.52% | +62.21% | +124.66% | +157.04% | +360.54% | 17.11B | |
| -0.55% | +2.83% | +3.41% | +22.41% | +9.18% | +70.85% | +191.99% | +70.32% | - | 16.41B | |
| +11.86% | +6.93% | +59.62% | +20.42% | -1.81% | +3.36% | +899.66% | +604.28% | +6,938.14% | 15.2B | |
| -0.95% | -0.15% | +15.77% | +36.31% | +15.14% | +18.06% | -23.86% | -8.93% | -30.29% | 13.42B | |
| -3.43% | -1.25% | -4.80% | -8.50% | +15.53% | +80.37% | +196.49% | +878.71% | +2,683.77% | 11.43B | |
| -1.74% | +2.91% | -0.39% | +11.86% | +37.05% | +131.65% | +169.08% | +533.93% | - | 10.16B | |
| +1.53% | +14.75% | +64.40% | +167.93% | +353.25% | +443.55% | +641.85% | +43.07% | - | 8.93B | |
| -0.66% | -1.28% | +6.41% | +4.77% | -6.36% | -18.47% | -25.22% | -53.07% | -48.62% | 7.11B | |
| -2.37% | +1.40% | +26.11% | +45.39% | +91.32% | +137.63% | +358.56% | +546.87% | - | 6.3B | |
| +0.94% | -6.90% | +11.83% | +31.34% | +5.58% | +5.64% | +73.77% | -9.12% | - | 6.3B | |
| +3.47% | +3.89% | +10.30% | +9.43% | +18.32% | +30.29% | +280.18% | +268.84% | - | 6.25B | |
| Average | -0.15% | +12.63% | +22.54% | +38.03% | +54.09% | +80.16% | +177.69% | +166.36% | +1,028.39% | 25.47B | |
| Weighted average by Cap. | -1.54% | +28.25% | +32.90% | +50.15% | +65.77% | +87.86% | +95.72% | +71.69% | +522.71% |
- Stock Market
- Stocks
- Stock
- Sector Idenix Pharmaceuticals Inc
Select your edition
All financial news and data tailored to specific country editions
